NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Bioo Scientific

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

New NEXTflex Rapid DNA-Seq Kit Provides Two-Hour NGS Library Construction from 1 ng of DNA - The NEXTflex™ Rapid DNA-Seq Kit allows gel-free library preparation for next generation sequencing in as little as two hours, using 1 ng - 1 µg of input DNA. This kit is available with up to 96 unique adapter barcodes for sample multiplexing
New NEXTflex Rapid DNA-Seq Kit Provides Two-Hour NGS Library Construction from 1 ng of DNA

 

NewswireTODAY - /newswire/ - Austin, TX, United States, 2013/06/17 - The NEXTflex™ Rapid DNA-Seq Kit allows gel-free library preparation for next generation sequencing in as little as two hours, using 1 ng - 1 µg of input DNA. This kit is available with up to 96 unique adapter barcodes for sample multiplexing.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Bioo Scientific’s NEXTflex™ Rapid DNA-Seq Kit allows researchers to build sequencing-ready libraries for sequencing on Illumina’s sequencing platforms from as little as 1 ng of DNA in two hours or less. This kit is ideal for use with genomic DNA, as well as FFPE samples, ChIP DNA and clinical samples.

The NEXTflex Rapid DNA-Seq Kit offers the flexibility to use between 1 ng - 1 µg of input DNA. A bead-based, gel-free size selection protocol eliminates the need for agarose gels in size selection, and the availability of up to 96 unique adapter barcodes facilitates high-throughput applications. The NEXTflex Rapid DNA-Seq Kit incorporates “Enhanced Adapter Ligation Technology”, which facilitates ligation of long adapters, resulting in longer and more diverse sequencing reads. Bioo Scientific’s NEXTflex Ligation and Polymerase reaction mixes ensure the highest quality libraries for superior performance.

According to Dr. Masoud Toloue, Director of Genomic Research at Bioo Scientific,“The NEXTflex Rapid DNA-Seq Kit offers the perfect balance of simplicity and speed without sacrificing library fidelity. This is achieved by optimizing the enzymatic reactions to allow multiple steps to be run simultaneously while avoiding bias that is inherent with enzymatic fragmentation and transposases.”

Bioo Scientific is an industry leader in the design and development of technology that minimizes bias and allows high levels of sample multiplexing to increase the efficiency and reduce the costs of NGS. The NEXTflex Rapid DNA-Seq Kit is the latest addition to Bioo Scientific’s line of innovative kits for next generation sequencing library preparation.

About Bioo Scientific Corporation

Bioo Scientific Corporation (biooscientific.com) provides innovative solutions to the life science industry. Bioo Scientific offers a complete portfolio of products that increase the sensitivity, flexibility and speed of next-generation sequencing.

Bioo Scientific’s products are used around the world and can be purchased directly or through global distribution networks with markets in more than 100 countries.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Bioo Scientific

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


New NEXTflex Rapid DNA-Seq Kit Provides Two-Hour NGS Library Construction from 1 ng of DNA

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Dawn Obermoeller - BiooScientific.com 
512-707-8993 dawno[.]biooscientific.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bioo Scientific securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Bioo Scientific / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

ONO PHARMA Presents Positive Results from Pivotal Trial in U.S. Patients with Relapsed or Refractory PCNSL At 2025 ASCO Annual Meeting
SCHOTT Pharma Expands Ready-to-use Portfolio with Sterile 1.5 ml Cartridge
Ono Commences Research Collaboration with Jorna Therapeutics to Generate Novel RNA Editing Therapeutics
SCHOTT Pharma Opens Production Facility in Serbia to Strengthen Competitiveness in Europe
NEC Has Developed Technologies that Enable A Secure Workflow for Personalized Cancer Vaccines and Has Proven their Capabilities
BASF Aroma Ingredients Innovates with Two New Isobionics® Biotech Flavor Ingredients
Federal Government Invests .9 Million in STEMCELL Technologies Canada, Inc.
Ono Enters into License Agreement with Ionis Pharmaceuticals for Sapablursen for the Treatment of Polycythemia Vera
Boehringer Ingelheim Partners with Veeva to Launch ‘One Medicine Platform’
U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)
U.S. Food and Drug Administration Approves Opdivo Qvantig™ (nivolumab & hyaluronidase-nvhy) Injection
NEC Announces Interim Results from Phase 1 Clinical Trial of NECVAX-NEO1
SCHOTT Pharma Unveils Innovative Nest Design for Ready-to-use Cartridges
Ipsen and Biomunex Announce Exclusive Global Licensing Agreement for First-in-class MAIT Cell Engager in Immuno-oncology
Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry through Consistent Quality Assurance, On-time Delivery

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2005-2025 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)